Your session is about to expire
← Back to Search
Behavioural Intervention
Multisensory Rehabilitation for Hemianopia
N/A
Recruiting
Led By Benjamin Rowland, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ability to perform the visual discriminations in their intact field
Diagnosis of a stable homonymous hemianopia (>6 months) with absence of hemineglect
Must not have
Adults (>85)
Inability to perform the visual discriminations in their intact field
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 3
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to help people who are blind in one half of their visual field by using training sessions with matching sights and sounds. The goal is to see if this can help their brains re-learn how to process visual information.
Who is the study for?
This trial is for adults under 85 years old with a stable condition called hemianopia, where half of the visual field is lost. Participants should not have attention deficits related to vision (hemineglect) and must be able to see well enough in their unaffected field to do certain visual tasks.
What is being tested?
The study tests a new way to help people with hemianopia, which involves using multiple senses in therapy. The goal is to show that this approach can improve vision problems caused by damage to the primary visual cortex while leaving other brain areas intact.
What are the potential side effects?
Since this trial focuses on rehabilitation through sensory exercises rather than medication or surgery, side effects are likely minimal but may include fatigue or frustration during training sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can see clearly with my unaffected eye.
Select...
I have had stable partial vision loss for over 6 months without ignoring one side.
Select...
My brain lesion affects my vision but not my touch or spatial awareness.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am over 85 years old.
Select...
I cannot see differences in shapes or colors correctly.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ month 3
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 3
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Distance between perceived and actual stimulus location
Humphrey visual field test
Low-vision visual functioning questionnaire (LV-VFQ-48)
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Unilaterally blind Subjects will be exposed to visual-auditory stimulationExperimental Treatment1 Intervention
The over-arching objective is to evaluate the functional recovery of vision in hemianopic patients engaged with a multisensory training paradigm. Unilaterally blind participants will participate in weekly training sessions in which they are exposed to high-density spatiotemporally congruent and consistent visual-auditory stimulation. The participants will be tested on a battery of visual tasks probing different levels of function in different environments in a longitudinal study to track recovery.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The multisensory rehabilitation paradigm for hemianopia involves using multiple sensory modalities to retrain the brain and improve visual function. This approach leverages the brain's neuroplasticity, encouraging it to reorganize and form new neural connections that compensate for the lost visual field.
By integrating visual, auditory, and tactile stimuli, patients can enhance their spatial awareness and visual processing capabilities. This is crucial for hemianopia patients as it can significantly improve their ability to perform daily activities, enhance their quality of life, and reduce the risk of accidents due to impaired vision.
The Effects of Continuous vs. Intermittent Prism Adaptation Protocols for Treating Visuospatial Neglect: A Randomized Controlled Trial.Effect of movement and vision on visual-motor adjustment to optical rearrangement.Changes in cerebral activation in individuals with and without visual vertigo during optic flow: A functional near-infrared spectroscopy study.
The Effects of Continuous vs. Intermittent Prism Adaptation Protocols for Treating Visuospatial Neglect: A Randomized Controlled Trial.Effect of movement and vision on visual-motor adjustment to optical rearrangement.Changes in cerebral activation in individuals with and without visual vertigo during optic flow: A functional near-infrared spectroscopy study.
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,403 Previous Clinical Trials
2,478,329 Total Patients Enrolled
Neuroscience Clinical Trial and Innovation Center (NCTIC)UNKNOWN
Benjamin Rowland, PhDPrincipal InvestigatorWake Forest Health Sciences
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am over 85 years old.I cannot see differences in shapes or colors correctly.I am willing to join the three-month program.I am under 85 years old.I can see clearly with my unaffected eye.I have had stable partial vision loss for over 6 months without ignoring one side.My brain lesion affects my vision but not my touch or spatial awareness.
Research Study Groups:
This trial has the following groups:- Group 1: Unilaterally blind Subjects will be exposed to visual-auditory stimulation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.